{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:09:31Z","timestamp":1778854171487,"version":"3.51.4"},"reference-count":29,"publisher":"BMJ","issue":"1","funder":[{"DOI":"10.13039\/501100000305","name":"National Eye Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000305","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NHS Executive South & West Research and Development Directorate"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>To describe a study to determine the influence of HLA class II matching on allograft rejection of high-risk, full-thickness corneal transplants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A prospective, longitudinal, clinical trial (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"ISRCTN25094892\" ext-link-type=\"isrctn\" specific-use=\"clinicaltrial pre-results\">ISRCTN25094892<\/jats:ext-link>) with a primary outcome measure of time to first clinically determined rejection episode. Tissue typing used DNA-based techniques. Corneas were allocated to patients with \u22642\u2009human leucocyte antigen (HLA) class I antigen mismatches by cohort minimisation to achieve 0, 1 or 2 HLA class II (HLA-DR) antigen mismatches. Transplants were to be followed up at 6 months and then annually on the anniversary of surgery for 5 years. Power calculations estimated a sample size of 856 transplants to detect a 0.1 difference in probability of rejection at 1\u2009year between HLA class II matched and mismatched transplants at the 5% level of significance with 80% power.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>To allow for loss to follow-up, 1133 transplants in 980 patients were accrued to the study between 3 September 1998 and 2 June 2011. 17% of transplants had 0 HLA-DR mismatches. The most frequent indication was bullous keratopathy, accounting for 27% of transplants and 54% of the transplants were regrafts. Median waiting time for a matched graft was 3 months. Donor and recipient characteristics were distributed evenly across the study groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Recruitment to the CFS II has closed with 1077\/1133 transplants meeting all the study criteria. Follow-up has been completed and final analysis of the data has started.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"ISRCTN25094892\" ext-link-type=\"isrctn\" specific-use=\"clinicaltrial pre-results\">ISRCTN25094892<\/jats:ext-link> andUKCRNID9871, Pre-results.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bjophthalmol-2017-311342","type":"journal-article","created":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T16:18:01Z","timestamp":1521735481000},"page":"132-136","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Corneal transplant follow-up study II (CTFS II): a prospective clinical trial to determine the influence of HLA class II matching on corneal transplant rejection: baseline donor and recipient characteristics"],"prefix":"10.1136","volume":"103","clinical-trial-number":[{"clinical-trial-number":"isrctn25094892","registry":"10.18810\/isrctn","type":"preResults"},{"clinical-trial-number":"isrctn25094892","registry":"10.18810\/isrctn","type":"postResults"},{"clinical-trial-number":"isrctn25094892","registry":"10.18810\/isrctn"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0154-8070","authenticated-orcid":false,"given":"W John","family":"Armitage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen L","family":"Winton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark N A","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie M","family":"Crewe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris A","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek M","family":"Tole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D","family":"Dick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,3,22]]},"reference":[{"key":"2020050713021251000_103.1.132.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.07.024"},{"key":"2020050713021251000_103.1.132.2","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000285489.91595.13"},{"key":"2020050713021251000_103.1.132.3","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.81.8.631"},{"key":"2020050713021251000_103.1.132.4","unstructured":"Williams KA , Lowe MT , Keane MC , et al . The Australian corneal graft registry 2012 report. Adelaide: Snap Printing, 2012."},{"key":"2020050713021251000_103.1.132.5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamaophthalmol.2015.4776","article-title":"Global survey of corneal transplantation and eye banking","volume":"134","author":"Gain","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"2020050713021251000_103.1.132.6","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.09-3994"},{"key":"2020050713021251000_103.1.132.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.09.019"},{"key":"2020050713021251000_103.1.132.8","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000269725.74189.b9"},{"key":"2020050713021251000_103.1.132.9","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2012.81"},{"key":"2020050713021251000_103.1.132.10","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.02-1255"},{"key":"2020050713021251000_103.1.132.11","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200008270-00018"},{"key":"2020050713021251000_103.1.132.12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000067653","article-title":"Histocompatibility and corneal transplantation","volume":"36","author":"V\u00f6lker-Dieben","year":"2003","journal-title":"Dev Ophthalmol"},{"key":"2020050713021251000_103.1.132.13","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/00007890-199511150-00026","article-title":"HLA-DR matching in corneal transplantation. Systematic review of published evidence. Corneal Transplant Follow-up Study Collaborators","volume":"60","author":"Gore","year":"1995","journal-title":"Transplantation"},{"key":"2020050713021251000_103.1.132.14","doi-asserted-by":"crossref","unstructured":"Sundmacher R , Adequate HLA matching in keratoplasty. Basel: Karger, 2003.","DOI":"10.1159\/isbn.978-3-318-00905-7"},{"key":"2020050713021251000_103.1.132.15","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1992.01080220054021"},{"key":"2020050713021251000_103.1.132.16","first-page":"1392","article-title":"Negative effect of HLA-DR matching on corneal transplant rejection","volume":"27","author":"Bradley","year":"1995","journal-title":"Transplant Proc"},{"key":"2020050713021251000_103.1.132.17","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0161-6420(86)33578-4","article-title":"HLA-A,B and DR matching in corneal transplantation","volume":"93","author":"Boisjoly","year":"1986","journal-title":"Ophthalmology"},{"key":"2020050713021251000_103.1.132.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(93)31409-0"},{"key":"2020050713021251000_103.1.132.19","doi-asserted-by":"publisher","DOI":"10.1016\/0198-8859(92)90062-R"},{"key":"2020050713021251000_103.1.132.20","doi-asserted-by":"publisher","DOI":"10.1080\/02713680701767884"},{"key":"2020050713021251000_103.1.132.21","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.ophtha.2009.06.006","article-title":"Long-term topical steroid treatment after penetrating keratoplasty in patients with pseudophakic bullous keratopathy","volume":"116","author":"Ross","year":"2009","journal-title":"Ophthalmology"},{"key":"2020050713021251000_103.1.132.22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1034\/j.1399-0039.2002.590507.x","article-title":"Predicting time on the waiting list for HLA matched corneal grafts","volume":"59","author":"B\u00f6hringer","year":"2002","journal-title":"Tissue Antigens"},{"key":"2020050713021251000_103.1.132.23","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/00007890-199102000-00049","article-title":"Evidence that the fate of class II-disparate corneal grafts is determined by the timing of class II expression","volume":"51","author":"Ross","year":"1991","journal-title":"Transplantation"},{"key":"2020050713021251000_103.1.132.24","first-page":"16","article-title":"Factors influencing the suitability of organ-cultured corneas for transplantation","volume":"38","author":"Armitage","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2020050713021251000_103.1.132.25","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-13386"},{"key":"2020050713021251000_103.1.132.26","doi-asserted-by":"crossref","unstructured":"Altman DG . Practical statistics for medical research. London: Chapman & Hall, 1991.","DOI":"10.1201\/9780429258589"},{"key":"2020050713021251000_103.1.132.27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.330.7495.843"},{"key":"2020050713021251000_103.1.132.28","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199611150-00017"},{"key":"2020050713021251000_103.1.132.29","first-page":"3","article-title":"Effectiveness of histocompatibility matching in high-risk corneal transplantation: a summary of results from the collaborative corneal transplantation studies","volume":"50","author":"Fink","year":"1994","journal-title":"Cesk Oftalmol"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2017-311342","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:56:30Z","timestamp":1601110590000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2017-311342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,22]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12,13]]},"published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.1136\/bjophthalmol-2017-311342"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311342","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,22]]}}}